Antibody-Mediated Clearance of Brain Amyloid-β: Mechanisms of Action, Effects of Natural and Monoclonal Anti-Aβ Antibodies, and Downstream Effects
David A. Loeffler
- ISSN / E-ISSN
- — / —
- DOI
- 10.3233/adr-230025 ↗
- Volume · Issue · Pages
- 7 · 1 · 873-899
- Publisher
- IOS Press BV
- Article URL
- https://doi.org/10.3233/adr-230025 ↗
- Article details
- Unverified
Publication date (each date has its type and source)
07 Aug 2023
OpenAlex publication date · source: OpenAlex
| Type | Date | Source |
|---|---|---|
| OpenAlex publication date | 07 Aug 2023 | OpenAlex |
Keywords (as given): Alzheimer's disease; amyloid-beta clearance; anti-amyloid monoclonal antibodies; aducanumab; lecanemab; donanemab; intravenous immunoglobulin; microglial phagocytosis; complement activation; tau aggregation; amyloid hypothesis; immunotherapy
HEC Status at Publication Not the journal's current status
HEC Status at PublicationConclusive
HEC status at publication
Recognized
Based on the recorded HEC dataset applicable to the article's publication date. Listed in the HEC list for 2023–24.
- Journal
- Journal of Alzheimer's Disease Reports
- Publication date used
- 07 Aug 2023 (OpenAlex publication date)
- Applicable HEC period
- 2023–24 (version 1) · 01 Jul 2023 – 30 Sep 2024
- Category
- —
- Recognition status
- Recognized (OK_RECORD_FOUND)
- Source
- HJRS 2023-24 page 2200, row 15501
- Verification status
- Verified against source · last verified 23 Sep 2026
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.
